L-DOPA animation (VIDEO)
Caption
Researchers at the University of Georgia are developing a new treatment for Parkinson's that aleviates the motor symptoms of the disease without the complications of dosage fluctuations that create different movement issues for patients. This video animation explains how researchers in the Isakson Center for Neurological Disease Research have engineered Escherichia coli Nissle 1917, a beneficial probiotic, to deliver a continuous dose of Levodopa, which converts to dopamine in the brain, in a single pill.
Credit
Lindsay Robinson/UGA Marketing and Communications
Usage Restrictions
None
License
Original content